Clinical Trial Update: Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France

View source ↗

Summary

A real-world French study evaluating quality of life in multiple sclerosis patients treated with ofatumumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis (MS) | Status: ACTIVE_NOT_RECRUITING